Suppr超能文献

足月引产时口服米索前列醇与 Foley 导管联合缩宫素的随机对照比较。

A randomized comparison of oral misoprostol versus Foley catheter and oxytocin for induction of labor at term.

作者信息

Abramovici D, Goldwasser S, Mabie B C, Mercer B M, Goldwasser R, Sibai B M

机构信息

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Tennessee, Memphis 38103, USA.

出版信息

Am J Obstet Gynecol. 1999 Nov;181(5 Pt 1):1108-12. doi: 10.1016/s0002-9378(99)70090-6.

Abstract

OBJECTIVE

We sought to compare the efficacy and safety of oral misoprostol administered to patients with the efficacy and safety in a control group treated with a Foley catheter and oxytocin for induction of labor.

STUDY DESIGN

Two hundred patients requiring induction of labor at term with a Bishop score of </=5 were randomized to receive oral misoprostol or a cervical Foley catheter plus oxytocin. Patients in the misoprostol group received 50 microg at 4-hour intervals for a maximum of 6 doses or until an adequate contraction pattern developed. Those in the control group had a Foley catheter inserted in the cervix, whereas oxytocin was administered intravenously by a standard incremental infusion protocol to a maximum dose of 36 mU/min.

RESULTS

In multiparous patients the percentage delivered of their neonates within 24 hours and the median induction-to-delivery times were similar in the 2 groups. In nulliparous patients, however, delivery within 24 hours was significantly less likely in the misoprostol group (53.4% vs 82. 5%; P <.001), and the median induction-to-delivery time was longer (23.3 hours vs 17.2 hours; P <.01). There were no differences in the incidence of meconium, chorioamnionitis, low Apgar scores, or cesarean delivery. The incidence of hyperstimulation was higher in the oxytocin-Foley group (4.1% vs 13.1%; P =.02).

CONCLUSION

Oral misoprostol is as effective as oxytocin-Foley catheter for inducing labor in multiparous women. Misoprostol appears less efficacious in nulliparous patients.

摘要

目的

我们试图比较口服米索前列醇用于引产患者的有效性和安全性与使用Foley导尿管加催产素的对照组的有效性和安全性。

研究设计

200例足月引产且Bishop评分≤5分的患者被随机分为两组,分别接受口服米索前列醇或宫颈Foley导尿管加催产素治疗。米索前列醇组患者每4小时口服50微克,最多6剂,或直至出现适当的宫缩模式。对照组患者在宫颈插入Foley导尿管,同时按照标准递增输注方案静脉注射催产素,最大剂量为36 mU/分钟。

结果

在经产妇中,两组在24小时内分娩的新生儿百分比以及引产至分娩的中位时间相似。然而,在初产妇中,米索前列醇组在24小时内分娩的可能性显著降低(53.4%对82.5%;P<.001),引产至分娩的中位时间更长(23.3小时对17.2小时;P<.01)。两组在胎粪、绒毛膜羊膜炎、低Apgar评分或剖宫产的发生率方面没有差异。催产素-Foley组的子宫收缩过强发生率更高(4.1%对13.1%;P=.02)。

结论

口服米索前列醇在经产妇引产方面与催产素-Foley导尿管同样有效。米索前列醇在初产妇中似乎效果较差。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验